Immunoconjugates and new targeted therapies against the KRAS gene are marking a significant advance in cancer research, as presented at the ENA 2026 congress in Barcelona, where innovative treatments for various types of tumors were discussed. #Cáncer #Inmunoconjugados #KRAS (translated)
